ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 61 filers reported holding ADC THERAPEUTICS SA in Q2 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,410,000 | -39.4% | 500,000 | 0.0% | 0.06% | -25.9% |
| Q2 2022 | $3,975,000 | -45.9% | 500,000 | 0.0% | 0.08% | -44.4% |
| Q1 2022 | $7,345,000 | -27.3% | 500,000 | 0.0% | 0.15% | -1.9% |
| Q4 2021 | $10,100,000 | -25.6% | 500,000 | 0.0% | 0.16% | -12.4% |
| Q3 2021 | $13,580,000 | +11.5% | 500,000 | 0.0% | 0.18% | +42.4% |
| Q2 2021 | $12,175,000 | -0.2% | 500,000 | 0.0% | 0.12% | +3.3% |
| Q1 2021 | $12,205,000 | -23.7% | 500,000 | 0.0% | 0.12% | -4.7% |
| Q4 2020 | $16,005,000 | -3.0% | 500,000 | 0.0% | 0.13% | +1.6% |
| Q3 2020 | $16,495,000 | -29.5% | 500,000 | 0.0% | 0.12% | -41.6% |
| Q2 2020 | $23,405,000 | – | 500,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,680,149 | $33,939,000 | 9.12% |
| Redmile Group, LLC | 7,451,029 | $150,511,000 | 3.42% |
| Grosvenor Holdings, L.L.C. | 1,517,212 | $30,648,000 | 3.17% |
| Indie Asset Partners, LLC | 96,582 | $1,951,000 | 1.42% |
| MPM BioImpact LLC | 337,396 | $6,815,000 | 1.24% |
| Eventide Asset Management | 1,975,000 | $39,895,000 | 0.51% |
| HHLR ADVISORS, LTD. | 500,000 | $10,100,000 | 0.16% |
| Virtus ETF Advisers LLC | 19,193 | $388,000 | 0.15% |
| CNA FINANCIAL CORP | 15,245 | $308,000 | 0.08% |
| Employees Retirement System of Texas | 278,000 | $5,616,000 | 0.06% |